Pay in 4 interest-free payments of $5.62 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
(1999) Thymosin beta-4 accelerates wound healing Research Applications Key Differences BPC-157 is more associated with cell signalling and repair pathways TB-500 is more associated with cell movement and structural reorganisation Important Notice: This content is provided for informational and research purposes only
Following the correct procedure is your best insurance against damaging the compound
The peptide has been studied across more than 100 peer-reviewed publications, with significant bodies of work published in the Journal of Pharmacological Sciences, Life Sciences, Journal of Physiology and Pharmacology, and Current Pharmaceutical Design
Legal Status and Availability BPC-157 is not FDA-approved for therapeutic use in the U.S., classified as a research chemical.[39][40] It is available through compounding pharmacies for educational or investigational purposes, often under veterinary or human research contexts
Selected Research Highlights Skin/Wound Models: TB-500 (T4) associated with faster re-epithelialization and contraction vs
Dissolving Your Peptide Correctly How you add the solvent matters as much as how much you add
